Atorvastatin up-regulate toxicologically relevant genes in rainbow trout gills

Ecotoxicology

Volumn 21, Issue 7, 2012, Pages 1841-1856

  Ellesat, Kathrin Sabine ^a   Holth, Tor Fredrik ^a   Wojewodzic, Marcin Wlodzimierz ^a   Hylland, Ketil ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Atorvastatin; Gene expression; Gill; Na+ K + ATPase; Rainbow trout

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATORVASTATIN; CASPASE 7; CYTOCHROME P450 3A; GERANYLTRANSFERASE; GLUCURONOSYLTRANSFERASE; GLUTAMATE CYSTEINE LIGASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LACTONE; METALLOTHIONEIN; MULTIDRUG RESISTANCE PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN BAX; SULFOTRANSFERASE; SUPEROXIDE DISMUTASE;

BIOTRANSFORMATION; CONCENTRATION (COMPOSITION); DRUG; ECOTOXICOLOGY; ENZYME; GENE EXPRESSION; INHIBITOR; JUVENILE; MEMBRANE; SALMONID; SODIUM;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BAX GENE; BIOTRANSFORMATION; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FDPS GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GILL; HMGR GENE; JUVENILE ANIMAL; LIVER; MEMBRANE TRANSPORT; MRP1 GENE; MT GENE; NONHUMAN; OXIDATIVE STRESS; PEROXISOME; PGP GENE; PPAR GENE; PRIORITY JOURNAL; RAINBOW TROUT; SOD GENE; TISSUE DISTRIBUTION; UPREGULATION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; GENE EXPRESSION; GILLS; HEPTANOIC ACIDS; LIVER; ONCORHYNCHUS MYKISS; PYRROLES; SODIUM-POTASSIUM-EXCHANGING ATPASE; UP-REGULATION; WATER POLLUTANTS, CHEMICAL;

MAMMALIA; ONCORHYNCHUS MYKISS;

EID: 84868123241     PISSN: 09639292     EISSN: 15733017     Source Type: Journal    
DOI: 10.1007/s10646-012-0918-z     Document Type: Article

References (104)

1. Atli G, Canli M (2008) Characterization of branchial Na,K-ATPase from three freshwater fish species (Oreochromis niloticus, Cyprinus carpio, and Oncorhynchus mykiss). Turk J Zool 32(3):299-304
2. Ballarè M, Campanini M, Airoldi G, Zaccala G, Bertoncelli M, Cornaglia G, Porzio M, Monteverde A (1992) Hepatotoxicity of hydroxy-methyl-glutaryl-coenzyme A reductase inhibitors. Minerva Gastroenterol Dietol 38(1):41-44
3. Barrett JC, Vainio H, Peakall D, Goldstein BD (1997) 12th Meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals: Susceptibility to environmental hazards. Environ Health Perspect 105:699-737
4. Bauermeister A, Lewendon A, Ramage PIN, Nimmo IA (1983) Distribution and some properties of the glutathione s-Transferase and [gamma]-glutamyl transpeptidase activities of rainbow trout. Comp Biochem Physiol C 74(1):89-93. doi:10.1016/0742-8413(83)90155-x
5. Bertrand-Thiebault C, Masson C, Siest G, Batt AM, Visvikis-Siest S (2007) Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line. J Cardiovasc Pharmacol 49(5):306-315
6. Bischoff H, Angerbauer R, Bender J, Bischoff E, Faggiotto A, Petzinna D, Pfitzner J, Porter MC, Schmidt D, Thomas G (1997) Cerivastatin: Pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor. Atherosclerosis 135(1): 119-130. doi:10.1016/s0021-9150(97)00188-3
7. Bowen C, Voeller HJ, Kikly K, Gelmann EP (1999) Synthesis of procaspases-3 and-7 during apoptosis in prostate cancer cells. Cell Death Differ 6(5):394-401
8. Buhler DR, Wang-Buhler J-L (1998) Rainbow trout cytochrome P450s: Purification, molecular aspects, metabolic activity, induction and role in environmental monitoring. Comp Biochem Physiol C 121(1-3):107-137
9. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT (2009) The MIQE guidelines: Minimum information for publication of quantitative teal-Time PCR experiments. Adv Clin Chem 55(4):611-622. doi:10.1373/clinchem.2008.112797
10. Callegari S, McKinnon RA, Andrews S, De Barros Lopes MA (2010) Atorvastatin-induced cell toxicity in yeast is linked to disruption of protein isoprenylation. FEMS Yeast Res 10(2):188-198. doi: 10.1111/j.1567-1364.2009. 00593.x
11. Caminada D, Zaja R, Smital T, Fent K (2008) Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1. Aquat Toxicol 90(3):214-222
12. Campbell NR, Overturf KEN, Narum SR (2009) Characterization of 22 novel single nucleotide polymorphism markers in steelhead and rainbow trout. Mol Ecol Resour 9(1):318-322. doi:10.1111/j.1755-0998.2008.02376.x
13. Cao P, Hanai J-I, Tanksale P, Imamura S, Sukhatme VP, Lecker SH (2009) Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect. FASEB J 23(9): 2844-2854. doi:10.1096/fj.08-128843
14. Chen C, Mireles RJ, Campbell SD, Lin J, Mills JB, Xu JJ, Smolarek TA (2005) Differential interaction of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors with ABCB1, ABCC2 and OATP1B1. Drug Metab Dispos 33(4):537-546
15. Choi JE, Kim S, Ahn JH, Youn P, Kang JS, Park K, Yi J, Ryu D-Y (2010) Induction of oxidative stress and apoptosis by silver nanoparticles in the liver of adult zebrafish. Aquat Toxicol 100(2):151-159. doi:10.1016/j.aquatox.2009. 12.012
16. Clarke DJ, George SG, Burchell B (1991) Glucuronidation in fish. Aquat Toxicol 20(1-2):35-56. doi:10.1016/0166-445x(91) 90040-g
17. Crockett EL (1998) Cholesterol function in plasma membranes from ectotherms: Membrane-specific roles in adaptation to temperature. Am Zool 38(2):291-304
18. Crockett EL, Hazel JR (1997) Cholesterol affects physical properties and (Na,K)-ATPase in basolateral membranes of renal and intestinal epithelia from thermally acclimated rainbow trout. J Comp Physiol B 167(5):344-351. doi:10.1007/s003600050083
19. Depledge MH (1996) Genetic ecotoxicology: An overview. J Exp Mar Biol Ecol 200(1-2):57-66. doi:10.1016/s0022-0981(96)02639-1
20. Dirks AJ, Jones KM (2006) Statin-induced apoptosis and skeletal myopathy. Am J Physiol Cell Physiol 291:C1208-C1212
21. Dorajoo RSO, Pereira BP, Yu Z, Gopalakrishnakone P, Leong CC, Wee A, Lee E (2008) Role of multi-drug resistance-Associated protein-1 transporter in statin-induced myopathy. Life Sci 82(15-16):823-830. doi:10.1016/j.lfs.2008.01. 021
22. Ellesat KS, Tollefsen KE, A ° sberg A, Thomas KV, Hylland K (2010) Cytotoxicity of atorvastatin and simvastatin on primary rainbow trout (Oncorhynchus mykiss) hepatocytes. Toxicol In Vitro 24(6):1610-1618. doi:10.1016/j.tiv.2010.06.006
23. Endo A, Kuroda M, Tanzawa K (1976) Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypercholesterolemic activity. FEBS Lett 72(2):323-326
24. Estey C, Chen X, Moon TW (2008) 3-Hydroxy-3-methylglutaryl coenzyme A reductase in rainbow trout: Effects of fasting and statin drugs on activities and mRNA transcripts. Comp Biochem Physiol C 147(3):386-398
25. Evans M, Rees A (2002) The myotoxicity of statins. Curr Opin Lipidol 13(4):415-420
26. Finne EF, Cooper GA, Koop BF, Hylland K, Tollefsen KE (2007) Toxicogenomic responses in rainbow trout (Oncorhynchus mykiss) hepatocytes exposed to model chemicals and a synthetic mixture. Aquat Toxicol 81:293-303
27. Fischer S, Pietsch M, Schirmer K, Luckenbach T (2010) Identification of multi-drug resistance associated proteins MRP1 (ABCC1) and MRP3 (ABCC3) from rainbow trout (Oncorhynchus mykiss). Mar Environ Res 69(Supplement 1):S7-S10. doi:10.1016/j.marenvres.2009.11.003
28. Fleige S, Pfaffl MW (2006) RNA integrity and the effect on the realtime qRT-PCR performance. Mol Aspects Med 27(2-3): 126-139. doi:10.1016/j.mam.2005. 12.003
29. Forman BM, Chen J, Evans RM (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-Activated receptors a and d. Proc Natl Acad Sci USA 94(9):4312-4317
30. Friesen JA, Rodwell VW (2004) The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases. Genome Biol 5(11):248. doi:10.1186/gb-2004-5-11-248
31. Gornati R, Papis E, Rimoldi S, Chini V, Terova G, Prati M, Saroglia M, Bernardini G (2005) Molecular markers for animal biotechnology: Sea bass (Dicentrarchus labrax, L.) HMG-CoA reductase mRNA. Gene 344:299-305. doi:10.1016/j.gene.2004.11.007
32. Gracia-Lor E, Sancho JV, Hernández F (2010) Simultaneous determination of acidic, neutral and basic pharmaceuticals in urban wastewater by ultra high-pressure liquid chromatography-Tandem mass spectrometry. J Chromatogr A 1217(5):622-632. doi: 10.1016/j.chroma.2009.11.090
33. Gray DF, Bundgaard H, Hansen PS, Buhagiar KA, Mihailidou AS, Jessup W, Kjeldsen K, Rasmussen HH (2000) HMG CoA reductase inhibition reduces sarcolemmal Na-Kpump density. Cardiovasc Res 47(2):329-335. doi:10.1016/s0008-6363(00)00 106-1
34. Greytak SR, Tarrant AM, Nacci D, Hahn ME, Callard GV (2010) Estrogen responses in killifish (Fundulus heteroclitus) from polluted and unpolluted environments are site-And gene-specific. Aquat Toxicol 99(2):291-299. doi:10.1016/j.aquatox.2010. 05.009
35. Grung M, Eldbjørg SH, Moe M, Schlabach M, Svenson A, Thomas K, Woldegiorgis A (2007) Human and veterinary pharmaceuticals, narcotics, and personal care products in the environment-current state of knowledge and monitoring requirements. Norwegian Pollution Control Authority, Oslo
36. Hernando M, Aguera A, Fernández-Alba A (2007) LC-MS analysis and environmental risk of lipid regulators. Anal Bioanal Chem 387(4):1269-1285
37. Holtzman CW, Wiggins BS, Spinler SA (2006) Role of P-glycoprotein in statin drug interaction. Pharmacotherapy 26(11): 1601-1607
38. Hook SE, Lampi MA, Febbo EJ, Ward JA, Parkerton TF (2010) Temporal patterns in the transcriptomic response of rainbow trout, Oncorhynchus mykiss, to crude oil. Aquat Toxicol 99(3):320-329. doi:10.1016/j.aquatox.2010.05.011
39. Hsieh CH, Jeng SF, Hsieh MW, Chen YC, Rau CS, Lu TH, Chen SS (2008) Statin-induced heme oxygenase-1 increases NF-kappa B activation and oxygen radical production in cultured neuronal cells exposed to lipopolysaccharide. Toxicol Sci 102(1): 150-159. doi:10.1093/toxsci/kfm298
40. Juliano RL, Ling V (1976) Surface glycoprotein modulating drug permeability in Chinese-hamster ovary cell mutants. Biochim Biophys Acta 455(1):152-162
41. Kaplan JH (2002) Biochemistry of Na,K-ATPase. Annu Rev Biochem 71(1):511-535. doi:10.1146/annurev.biochem.71. 102201.141218
42. Kearney AS, Crawford LF, Mehta SC, Radebaugh GW (1993) The interconversion kinetics, equilibrium, and solubilities of the lactone and hydroxyacid forms of the HMG-CoA reductase inhibitor, CI-981. Pharm Res 10(10):1461-1465
43. Khetan SK, Collins TJ (2007) Human pharmaceuticals in the aquatic environment: A challenge to green chemistry. Chem Rev 107(6):2319-2364. doi:10.1021/cr020441w
44. Kirchner S, McDaniel N, Suguira S, Scoteropoulos P, Tian B, Fletcher J, Ferraris R (2007) Salmonid microarrays identify intestinal genes that reliably monitor P deficiency in rainbow trout aquaculture. Animal Genet 38:319-331
45. Kliewer SA, Goodwin B, Willson TM (2002) The nuclear pregnane X receptor: A key regulator of xenobiotic metabolism. Endocr Rev 23(5):687-702. doi:10.1210/er.2001-0038
46. Knauer MJ, Urquhart BL, Schwabedissen H, Schwarz UI, Lemke CJ, Leake BF, Kim RB, Tirona RG (2010) Human skeletal muscle drug transporters determine local exposure and toxicity of statins. Circ Res 106(2):297-306. doi:10.1161/ circresaha.109.203596
47. Ko M-J, Ahn J-I, Shin HJ, Kim HS, Chung HJ, Jeong H-S (2010) Gene expression analysis for statin-induced cytotoxicity from rat primary hepatocytes. Genome Inform 8(1):41-49
48. Kocarek TA, Schuetz EG, Guzelian PS (1993) Regulation of phenobarbital-inducible cytochrome-P450 2B1/2 mRNA by lovastatin and oxysterols in primary cultures of adult rat hepatocytes. Toxicol Appl Pharmacol 120(2):298-307. doi: 10.1006/taap.1993.1115
49. Kolditz C, Borthaire M, Richard N, Corraze G, Panserat S, Vachot C, Lefevre F, Medale F (2008) Liver and muscle metabolic changes induced by dietary energy content and genetic selection in rainbow trout (Oncorhynchus mykiss). Am J Physiol Regul Integr Comp Physiol 294(4):R1154-R1164. doi:10.1152/ajpregu. 00766.2007
50. Kroemer G, Martin SJ (2005) Caspase-independent cell death. Nat Med 11(7):725-730. doi:10.1038/nm1263
51. Kubota T, Fujisaki K, Itoh Y, Yano T, Sendo T, Oishi R (2004) Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. Biochem Pharmacol 67(12): 2175-2186. doi:10.1016/j.bcp.2004.02.037
52. Lahti M, Brozinski J-M, Jylha A, Kronberg L, Oikari A (2011) Uptake from water, biotransformation, and biliary excretion of pharmaceuticals by rainbow trout. Environ Toxicol Chem 30(6):1403-1411. doi:10.1002/etc.501
53. Landmesser U, Bahlmann F, Mueller M, Spiekermann S, Kirchhoff N, Schulz S, Manes C, Fischer D, de Groot K, Fliser D, Fauler G, Marz W, Drexler H (2005) Simvastatin versus ezetimibe-pleiotropic and lipid-lowering effects on endothelial function in humans. Circulation 111(18):2356-2363. doi:10.1161/01.cir. 0000164260.82417.3f
54. Langford K, Thomas KV (2011) Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment. J Environ Monit 13(2):416-421. doi:10.1039/c0em00342e
55. Larno V, Laroche J, Launey S, Flammarion P, Devaux A (2001) Responses of chub (Leuciscus cephalus) populations to chemical stress, assessed by genetic markers, DNA damage and cytochrome P4501A induction. Ecotoxicology 10(3):145-158. doi: 10.1023/a:1016637809483
56. Lee J, Hong E, Koh D, Choi M, Jang H, Kae S, Choi H (2010) HMGCoA reductase inhibitors (statins) activate expression of PPARa/PPARc and ABCA1 in cultured gallbladder epithelial cells. Dig Dis Sci 55(2):292-299
57. Lennernas H (2003) Clinical pharmacokinetics of atorvastatin. Clin Pharmacokinet 42(13):1141-1160
58. Levine SL, Oris JT (1999) CYP1A expression in liver and gill of rainbow trout following waterborne exposure: Implications for biomarker determination. Aquat Toxicol 46(3-4):279-287. doi: 10.1016/s0166-445x(98)00124-6
59. Liu G, Moon TW, Metcalfe CD, Lee LEJ, Trudeau VL (2005) A teleost in vitro reporter gene assay to screen for agonists of the peroxisome proliferator-Activated receptors. Environ Toxicol Chem 24(9):2260-2266
60. Loncar J, Popovic M, Zaja R, Smital T (2010) Gene expression analysis of the ABC efflux transporters in rainbow trout (Oncorhynchus mykiss). Comp Biochem Physiol C 151(2):209-215. doi:10.1016/j.cbpc.2009.10.009
61. Marino M, Di Masi A, Trezza V, Pallottini V, Polticelli F, Ascenzi P (2011) Xenosensors CAR and PXR at work: Impact on statin metabolism. Curr Drug Metab 12(3):300-311
62. Martin G, Duez H, Blanquart C, Berezowski V, Poulain P, Fruchart JC, Najib-Fruchart J, Glineur C, Staels B (2001) Statin-induced inhibition of the Rho-signaling pathway activates PPAR alpha and induces HDL apoA-I. J Clin Invest 107(11):1423-1432
63. McCormick SD, Bern HA (1989) In vitro stimulation of Na-K-ATPase activity and ouabain binding by cortisol in coho salmon gill. Am J Physiol Regul Integr Comp Physiol 256(3):R707-R715
64. Meisenberg G, Simmons W (2006) Principles of medical biochemistry, 2nd edn. Mosby Elsevier, Philadelphia.
65. Metcalfe CD, Miao XS, Koenig BG, Struger J (2003) Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ Toxicol Chem 22(12):2881-2889
66. Minghetti M, Leaver MJ, Tocher DR (2011) Transcriptional control mechanisms of genes of lipid and fatty acid metabolism in the Atlantic salmon (Salmo salar L.) established cell line, SHK-1. Biochim Biophys Acta Mol Cell Biol Lipids 1811(3):194-202. doi:10.1016/j.bbalip.2010.12.008
67. Morikawa S, Murakami T, Yamazaki H, Izumi A, Saito Y, Hamakubo T, Kodama T (2005) Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins. J Atheroscler Thromb 12(3):121-131
68. Ness GC, Chambers CM (2000) Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: The concept of cholesterol buffering capacity. Proc Soc Exp Biol Med 224(1):8-19. doi:10.1111/j.1525-1373. 2000.22359.x
69. Niemi M (2009) Transporter pharmacogenetics and statin toxicity. Clin Pharmacol Ther 87(1):130-133. doi:10.1038/clpt.2009.197
70. Niemi M, Pasanen MK, Neuvonen PJ (2011) Organic anion transporting polypeptide 1B1: A genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev 63(1):157-181. doi:10.1124/pr.110.002857
71. Oleksiak MF, Churchill GA, Crawford DL (2002) Variation in gene expression within and among natural populations. Nat Genet 32(2):261-266
72. Owaczarek J, Jasinska M, Orszulak-Michalak D (2005) Drug-induced myopathies. An overview of the possible mechanisms. Pharm Represent 57:23-34
73. Perfettini J-L, Reed JC, Israel N, Martinou J-C, Dautry-Varsat A, Ojcius DM (2002) Role of Bcl-2 family members in caspaseindependent apoptosis during chlamydia infection. Infect Immun 70(1):55-61. doi:10.1128/iai.70.1.55-61.2002
74. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST-) for group-wise comparison and statistical analysis of relative expression results in real-Time PCR. Nucleic Acids Res 30(9):e36. doi:10.1093/nar/30.9.e36
75. Piecha M, Sarakha M, Trebse P, Kocar D (2009) Stability studies of cholesterol lowering statin drugs in aqueous samples using HPLC and LC-MS. Environ Chem Lett 8(2):185-191. doi: 10.1007/s10311-009-0207-0
76. Prindiville JS, Mennigen JA, Zamora JM, Moon TW, Weber J-M (2011) The fibrate drug gemfibrozil disrupts lipoprotein metabolism in rainbow trout. Toxicol Appl Pharmacol 251(3): 201-208. doi:10.1016/j.taap.2010.12.013
77. Prueksaritanont T, Subramanian R, Fang X, Ma B, Qiu Y, Lin JH, Pearson PG, Baillie TA (2002) Glucuronidation of statins in animals and humans: A novel mechanism of statin lactonization. Drug Metab Dispos 30(5):505-512. doi:10.1124/dmd.30.5.505
78. Rabkin S, Lodha P, Kong J (2007) Reduction of protein synthesis and statin-induced cardiomyocyte cell death. Cardiovasc Toxicol 7(1):1-9. doi:10.1007/s12012-007-0003-7
79. Risso-de Faverney C, Orsini N, de Sousa G, Rahmani R (2004) Cadmium-induced apoptosis through the mitochondrial pathway in rainbow trout hepatocytes: Involvement of oxidative stress. Aquat Toxicol 69(3):247-258
80. Rodrigues AC (2010) Efflux and uptake transporters as determinants of statin response. Expert Opin Drug Metab Toxicol 6(5): 621-632. doi:10.1517/17425251003713519
81. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds) Bioinformatics methods and protocols: Methods in molecular biology, vol 132. Humana Press, Totowa, pp 365-386
82. Rudling M, Angelin B, Stahle L, Reihner E, Sahlin S, Olivecrona H, Bjorkhem I, Einarsson C (2002) Regulation of hepatic lowdensity lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liver. J Clin Endocrinol Metab 87(9):4307-4313. doi: 10.1210/jc.2002-012041
83. Sacher J, Weigl L, Werner M, Szegedi C, Hohenegger M (2005) Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells. J Pharmacol Exp Ther 314:1032-1041
84. Sakshaug S, Strøm H, Berg CL, Litleskare I, Blix HS, Rønning M, Granum T (2011) Drug consumption in Norway 2006-2010 (Legemiddelforbruket i Norge 2006-2010). Norwegian Institute of Public Health, Oslo
85. Sanchez CA, Rodriguez E, Varela E, Zapata E, Paez A, Masso FA, Montano LF, Lopez-Marure R (2008) Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress. Cancer Invest 26(7):698-707. doi: 10.1080/07357900701874658
86. Schmitz G, Schmitz-Madry A, Ugocsai P (2007) Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy. Curr Opin Lipidol 18:164-173
87. Sirvent P, Mercier J, Vassort G, Lacampagne A (2005) Simvastatin triggers mitochondria-induced Ca2 signaling alteration in skeletal muscle. Biochem Biophys Res Commun 329(3): 1067-1075
88. Sirvent P, Mercier J, Lacampagne A (2008) New insights into mechanisms of statin-Associated myotoxicity. Curr Opin Pharmacol 8(3):333-338
89. Skiba-Cassy S, Lansard M, Panserat S, Medale F (2009) Rainbow trout genetically selected for greater muscle fat content display increased activation of liver TOR signaling and lipogenic gene expression. Am J Physiol Regul Integr Comp Physiol 297(5):R1421-R1429. doi:10.1152/ajpregu.00312.2009
90. Skottheim IB, Gedde-Dahl A, Hejazifar S, Hoel K, A ° sberg A (2008) Statin induced myotoxicity: The lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro. Eur J Pharm Sci 33(4-5):317-325
91. Sturm A, Segner H (2005) P-glycoproteins and xenobiotic efflux transport in fish. In: Mommsen TP, Hochachka PW (eds) Biochemistry and molecular biology of fishes, vol 6. Elsevier, Amsterdam, pp 495-533
92. Sturm A, Ziemann C, Hirsch-Ernst KI, Segner H (2001) Expression and functional activity of P-glycoprotein in cultured hepatocytes from Oncorhynchus mykiss. Am J Physiol Regul Integr Comp Physiol 281(4):R1119-R1126
93. Takle H, Andersen Ø (2007) Caspases and apoptosis in fish. J Fish Biol 71(sc):326-349
94. Thorpe JL, Doitsidou M, Ho S-Y, Raz E, Farber SA (2004) Germ cell migration in zebrafish is dependent on HMGCoA reductase activity and prenylation. Dev Cell 6(2):295-302
95. Vandesompele J, Preter KD, Pattyn F, Poppe B, Roy NV, Paepe AD, Speleman F (2001) Accurate normalization of real-Time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3(7):research0034.1-research0034.11
96. Wagner AH, Kohler T, Ruckschloss U, Just I, Hecker M (2000) Improvement of nitric oxide-dependent vasodilatation by HMGCoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 20(1):61-69
97. Wagner M, Halilbasic E, Marschall HU, Zollner G, Fickert P, Langner C, Zatloukal K, Denk H, Trauner M (2005) CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42(2):420-430. doi:10.1002/hep.20784
98. Wang E, Casciano CN, Clement RP, Johnson WW (2001) HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein. Pharm Res 18(6):800-806
99. Wassmur B, Grans J, Kling P, Celander MC (2010) Interactions of pharmaceuticals and other xenobiotics on hepatic pregnane X receptor and cytochrome P450 3A signaling pathway in rainbow trout (Oncorhynchus mykiss). Aquat Toxicol 100(1):91-100. doi: 10.1016/j.aquatox.2010.07.013
100. Wiseman S, Osachoff H, Bassett E, Malhotra J, Bruno J, Van Aggelen G, Mommsen TP, Vijayan MM (2007) Gene expression pattern in the liver during recovery from an acute stressor in rainbow trout. Comp Biochem Physiol Part D Genom Proteom 2(3): 234-244
101. Yamasaki D, Nakamura T, Okamura N, Kokudai M, Inui N, Takeuchi K, Watanabe H, Hirai M, Okumura K, Sakaeda T (2009) Effects of acid and lactone forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the induction of MDR1 expression and function in LS180 cells. Eur J Pharm Sci 37(2): 126-132
102. Zar JH (1999) Biostatistical analysis, 4th edn. Prentice Hall, Upper Saddle River
103. Zhang X, Oakes KD, Cui S, Bragg L, Servos MR, Pawliszyn J (2010) Tissue-specific in vivo bioconcentration of pharmaceuticals in rainbow trout (Oncorhynchus mykiss) using space-resolved solid-phase microextraction. Environ Sci Technol 44(9): 3417-3422. doi:10.1021/es903064t
104. Zurita JL, Repetto G, Jos A, Salguero M, Lopez-Artiguez M, Camean AM (2007) Toxicological effects of the lipid regulator gemfibrozil in four aquatic systems. Aquat Toxicol 81(1):106-115. doi:10.1016/j.aquatox.2006.11.007